HDAC1 and primary cutaneous T-cell non-Hodgkin lymphoma: HDAC1 and HDAC2 are upregulated in DLBCL, peripheral T-cell leukemias, cutaneous T-cell lymphomas and NK/T-cell lymphomas and the expression of HDAC1 was found to be related to worse prognosis in patients (Min et al., 2012).